LIFE BIOSCIENCES
LIVE

Serial Number

97424475

Owner

Life Biosciences Inc.

Attorney

Brendan J. Hughes

Filing Date

May 23, 2022

Add to watchlist:

No watchlists yet
View on USPTO

LIFE BIOSCIENCES Trademark

Serial Number: 97424475

LIFE BIOSCIENCES is a trademark filed by Life Biosciences Inc. on May 23, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Life Biosciences Inc. (3 trademarks)

31 Saint James Avenue, 6th Floor
Boston, MA 021164128

Entity Type: 03

Trademark Details

Filing Date

May 23, 2022

Registration Date

Not Registered

Published for Opposition

December 19, 2023

Goods & Services

Pharmaceutical preparations for prevention and treatment of diseases, disorders, and degenerative conditions associated with aging, namely, auditory, bone, cardiovascular, central nervous system, dermatological, endocrine, genetic, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, joint, integumentary, reproductive, otolaryngological, and sensory diseases, disorders and conditions; Pharmaceutical preparations for the diagnosis, prevention and treatment of chronic diseases, conditions and functional disorders namely, auditory, bone, cardiovascular, central nervous system, dermatological, endocrine, genetic, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, joint, integumentary, reproductive, otolaryngological, sensory diseases, conditions, and disorders; Pharmaceutical preparations for diagnosis, prevention and treatment of diseases by gene therapy, namely, auditory, bone, cardiovascular, central nervous system, dermatological, endocrine, genetic, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, joint, integumentary, reproductive, otolaryngological, sensory diseases; neutraceuticals and cosmeceuticals both for use as a dietary supplement that mitigate aging, treat immunological diseases and degenerative conditions of the body, promote life extension, and restore bodily functions

Medical diagnostics services; medical services for the diagnosis of diseases, disorders and degenerative conditions associated with aging

Filing History

TEAS STATEMENT OF USE RECEIVED
Jul 24, 2026 EISU
TEAS REQUEST TO DIVIDE RECEIVED
Jul 24, 2026 ERTD
SOU TEAS EXTENSION RECEIVED
Jul 24, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 28, 2026 EXRA
SOU EXTENSION 4 GRANTED
Jan 27, 2026 EX4G
SOU EXTENSION 4 FILED
Jan 27, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 27, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 25, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jul 24, 2025 EX3G
SOU EXTENSION 3 FILED
Jul 24, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 24, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 18, 2024 EXRA
SOU EXTENSION 2 GRANTED
Dec 18, 2024 EX2G
SOU EXTENSION 2 FILED
Dec 18, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 18, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 5, 2024 EXRA
SOU EXTENSION 1 GRANTED
Aug 5, 2024 EX1G
SOU EXTENSION 1 FILED
Aug 5, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 5, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 13, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 19, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 19, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 29, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 15, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 14, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 29, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 29, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 30, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 30, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 30, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 25, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 24, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 21, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 21, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 21, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 10, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2022 NWOS
NEW APPLICATION ENTERED
May 26, 2022 NWAP